December 19, 2022
Life Sciences
  • The Food and Drug Administration (FDA) declared a shortage of Eli Lilly & Co.’s diabetes drug Mounjaro. The FDA informed pharmacies that they should expect full shipment delays for 5-milligram doses. However, the University of Utah drug information service, which tracks drug shortages, said that 2.5-milligram and 7.5-milligram doses are also on backorder. (Article here)
Return to Tea Leaves